GO:0045932 negative regulation of muscle contraction: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045932 (negative regulation of muscle contraction) describes any process that stops, prevents, or reduces the frequency, rate, or extent of muscle contraction.
• Negative regulation occurs at multiple levels: calcium handling, thin-filament regulation, Gq-coupled receptor feedback, and post-translational modification of contractile proteins [1,3,4,5].
• Key molecular players include diacylglycerol kinase (DGK), p300/CBP acetyltransferases, sarcoplasmic reticulum Ca2+-ATPase (SERCA), and thin-filament proteins such as troponin and tropomyosin [1,3,5,6].
• Dysregulation of negative regulation contributes to airway hyperresponsiveness, gastric motility disorders, and skeletal myopathies [1,4,6].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of negative regulatory nodes in muscle contraction [3,6].
• Understanding this process informs therapeutic strategies for asthma, gastrointestinal dysmotility, and inherited muscle diseases [1,4,6].
Description
Muscle contraction is a tightly controlled process, and its negative regulation ensures that contraction is terminated or attenuated when appropriate. GO:0045932, negative regulation of muscle contraction, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of muscle contraction. This regulation is essential for normal physiology, preventing excessive contraction in smooth muscle of the airways and gastrointestinal tract, and modulating force output in skeletal and cardiac muscle [1,4,6]. At the molecular level, negative regulation can occur through feedback inhibition of Gq signaling, calcium sequestration by the sarcoplasmic reticulum, and post-translational modifications of contractile proteins [1,3,5]. Researchers study this term to understand how cells avoid hypercontractility and how its failure leads to disease. For example, inhibition of diacylglycerol kinase reduces airway contraction by negative feedback on Gq signaling, highlighting a druggable node. Similarly, mutations in thin filament proteins impair regulation and cause skeletal myopathies. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0045932, its mechanisms, key genes, and experimental approaches.
negative regulation of muscle contraction At A Glance
| GO ID | GO:0045932 |
|---|---|
| GO term | negative regulation of muscle contraction |
| Ontology | biological_process |
| Synonym | down regulation of muscle contraction, down-regulation of muscle contraction, downregulation of muscle contraction, inhibition of muscle contraction |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of muscle contraction |
| Related processes | Regulation of calcium handling, Gq signaling feedback, thin filament regulation, post-translational modification of contractile proteins |
| Key regulators | DGK, p300/CBP, SERCA, troponin, tropomyosin, calcium channels |
| Disease relevance | Airway hyperresponsiveness, gastric motility disorders, skeletal myopathies |
What Is GO:0045932?
According to the Gene Ontology, GO:0045932 (negative regulation of muscle contraction) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of muscle contraction. It is a biological process that acts as a negative regulator of the contraction process, encompassing molecular events such as inhibition of calcium release, enhancement of calcium reuptake, and modulation of contractile protein activity [1,3,4,5].
Why Is negative regulation of muscle contraction Important in Cell Biology?
Negative regulation of muscle contraction is critical for maintaining normal physiological function and preventing pathological hypercontractility. In smooth muscle, excessive contraction can lead to bronchoconstriction in asthma or gastrointestinal spasms, while in skeletal muscle, defective regulation causes myopathies [1,4,6]. Understanding the molecular mechanisms of negative regulation provides targets for therapeutic intervention and informs the development of drugs that modulate contraction [1,8].
• Prevents excessive airway smooth muscle contraction in asthma and COPD.
• Regulates gastric and intestinal motility to avoid spasm or dysmotility.
• Modulates skeletal muscle force and fatigue [3,7].
• Involved in calcium homeostasis and excitation-contraction coupling [4,5].
• Dysregulation linked to inherited myopathies due to thin filament mutations.
• Provides targets for calcium-channel blocking agents used in cardiovascular therapy.
• Impacts energy metabolism and ATP supply during contraction.
• Circadian regulation of muscle contraction affects mTOR signaling and protein synthesis.
• Post-translational acetylation by p300/CBP modulates contractile function.
• Sarcoplasmic reticulum dynamics influence contraction relaxation via Ca2+-ATPase.
What Happens During negative regulation of muscle contraction?
Feedback inhibition of Gq signaling
In simple terms: Cells can turn down contraction signals by breaking down a messenger molecule called DAG.
Diacylglycerol kinase (DGK) phosphorylates diacylglycerol (DAG) to phosphatidic acid, thereby terminating DAG-mediated activation of protein kinase C and other effectors downstream of Gq-coupled receptors. In airway smooth muscle, inhibition of DGK reduces contraction by enhancing negative feedback regulation of Gq signaling. This mechanism exemplifies how negative regulation of muscle contraction can occur through receptor-desensitization pathways.
Calcium sequestration by sarcoplasmic reticulum
In simple terms: Calcium is pumped back into storage to stop contraction.
The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) actively transports Ca2+ from the cytosol into the SR lumen, lowering intracellular Ca2+ and promoting muscle relaxation. In scallop SR vesicles, Ca2+-dependent formation and collapse of cylindrical Ca2+-ATPase crystals suggest a dynamic role of SR in regulating contraction. This calcium sequestration is a primary mechanism for negative regulation of muscle contraction.
Thin filament regulation
In simple terms: Proteins on the thin filament can block the interaction that causes contraction.
In striated muscle, troponin and tropomyosin regulate the access of myosin to actin. Mutations in thin filament proteins associated with skeletal myopathies lead to defective regulation of muscle contraction, often impairing the inhibitory switch that prevents contraction in the absence of calcium. Thus, proper thin filament function is essential for negative regulation.
Post-translational modification of contractile proteins
In simple terms: Adding chemical tags to contractile proteins can alter how strongly muscles contract.
Acetyltransferases p300 and CBP post-translationally modify skeletal muscle contractile proteins, influencing contractile function. Insights into their regulation reveal that acetylation can modulate the contractile apparatus, potentially contributing to negative regulation of muscle contraction under certain conditions. This adds a layer of epigenetic and post-translational control.
Calcium channel blockade
In simple terms: Blocking calcium channels reduces calcium entry, which decreases contraction.
Calcium-channel blocking agents inhibit the influx of extracellular Ca2+ into muscle cells, leading to reduced contraction. These agents are used clinically to treat hypertension and angina, demonstrating the therapeutic relevance of negative regulation of muscle contraction.
Key Genes Involved in GO:0045932 negative regulation of muscle contraction
The following genes and proteins are key players in the negative regulation of muscle contraction, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DGK | Phosphorylates DAG to terminate Gq signaling | Target for reducing airway contraction |
| p300 | Acetyltransferase modifying contractile proteins | Post-translational regulation of contraction |
| CBP | Acetyltransferase modifying contractile proteins | Post-translational regulation of contraction |
| SERCA | Ca2+-ATPase pumping Ca2+ into SR | Calcium sequestration and relaxation |
| TNNI | Troponin I, inhibits actomyosin ATPase | Thin filament regulation; mutations cause myopathy |
| TNNT | Troponin T, binds tropomyosin | Thin filament regulation; mutations cause myopathy |
| TPM | Tropomyosin, blocks myosin binding sites | Thin filament regulation; mutations cause myopathy |
| MYH | Myosin heavy chain, motor protein | Contraction and its regulation |
| ACTA1 | Actin, thin filament component | Contraction and its regulation |
| mTOR | Kinase regulating protein synthesis | Time-of-day effect of contraction on mTOR signaling |
| CACNA1C | Voltage-gated calcium channel | Calcium entry and contraction; target of blockers |
| CACNA1S | Voltage-gated calcium channel | Calcium entry and contraction; target of blockers |
| RYR | Ryanodine receptor, calcium release channel | Excitation-contraction coupling |
| IP3R | Inositol trisphosphate receptor | Gq signaling and calcium release |
| PKC | Protein kinase C, downstream of DAG | Modulates contraction |
| MLCK | Myosin light chain kinase | Phosphorylates myosin light chain to initiate contraction |
| MLCP | Myosin light chain phosphatase | Dephosphorylates myosin light chain to relax |
How Is negative regulation of muscle contraction Regulated?
Negative regulation of muscle contraction is itself regulated by various signaling pathways. For instance, diacylglycerol kinase activity is modulated by phosphorylation and calcium/calmodulin, providing feedback control. The acetyltransferases p300 and CBP are regulated by their own expression levels and post-translational modifications, affecting contractile protein acetylation. Calcium-dependent processes, such as the formation of Ca2+-ATPase crystals in the sarcoplasmic reticulum, are dynamically regulated by calcium concentrations. Additionally, time-of-day effects on high-intensity muscle contraction influence mTOR signaling and protein synthesis, suggesting circadian regulation of contraction-related pathways.
negative regulation of muscle contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DGK | Airway hyperresponsiveness | Knockout or overexpression in airway smooth muscle cells |
| TNNI | Skeletal myopathy | Point mutation knock-in in mouse models |
| TPM | Skeletal myopathy | Knock-in of patient mutations |
| CACNA1C | Hypertension, angina | Knockout or point mutation in vascular smooth muscle |
| SERCA | Muscle relaxation defects | Overexpression or knockout in muscle cells |
Airway hyperresponsiveness and asthma
In asthma, excessive airway smooth muscle contraction leads to bronchoconstriction. Negative regulation of muscle contraction is impaired, and enhancing this regulation could be therapeutic. Inhibition of diacylglycerol kinase reduces airway contraction by negative feedback regulation of Gq signaling, highlighting a potential target.
Gastric motility disorders
In the gastrointestinal tract, negative feedback regulation of excitation-contraction coupling in gastric smooth muscle is essential for normal motility. Disruption of this regulation can lead to dysmotility, spasms, or gastroparesis.
Skeletal myopathies
Mutations in thin filament proteins such as troponin and tropomyosin cause skeletal myopathies characterized by defective regulation of muscle contraction. These mutations impair the inhibitory mechanisms that prevent excessive or inappropriate contraction, leading to muscle weakness and wasting.
Cardiovascular disorders
Calcium-channel blocking agents are used to treat hypertension and angina by reducing calcium entry and thus negative regulation of muscle contraction in vascular smooth muscle. Their efficacy demonstrates the clinical importance of this process.
From negative regulation of muscle contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DGK enhance airway contraction? | DGK knockout mouse or CRISPR KO in human airway smooth muscle cells |
| Do thin filament mutations impair negative regulation? | Knock-in of TNNI or TPM mutations in mice |
| How does acetylation affect contractile function? | p300/CBP knockout or overexpression in skeletal muscle |
| What is the role of SERCA in relaxation? | SERCA overexpression or KO in muscle cells |
| How does circadian rhythm affect contraction regulation? | Time-of-day controlled contraction experiments in mice |
| Can calcium channel blockers modulate contraction? | In vitro contraction assays with CACNA1C mutations |
How to Study the negative regulation of muscle contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular Ca2+ levels | Assess calcium handling in muscle cells [1,5] |
| Contractility assay | Force or shortening | Test negative regulation in smooth or skeletal muscle [1,4] |
| Western blot | Protein expression and modifications | Detect acetylation of contractile proteins |
| Mass spectrometry | Protein acetylation sites | Identify p300/CBP targets |
| CRISPR knockout | Gene function loss | Study DGK, SERCA, or thin filament genes [1,6] |
| Knock-in | Mutant protein expression | Model myopathy mutations |
| RNA-seq | Transcriptional changes | Identify pathways co-regulated with contraction |
| Proteomics | Protein abundance and modifications | Global analysis of contractile apparatus |
Calcium imaging
Calcium imaging using fluorescent indicators (e.g., Fura-2, Fluo-4) measures intracellular Ca2+ transients in muscle cells, providing direct readout of calcium handling during negative regulation of contraction [1,5].
Contractility assays
Muscle contractility assays, such as force measurements in isolated muscle strips or gel contraction assays, quantify the extent of contraction and its inhibition. These are used to test the effects of genetic manipulations or drugs [1,4].
Post-translational modification analysis
Western blotting with pan-acetyl antibodies or mass spectrometry can detect acetylation of contractile proteins, revealing how p300/CBP modulate contraction.
Genetic manipulation with CRISPR
CRISPR-Cas9 knockout, point mutation, or knock-in of genes such as DGK, TNNI, or SERCA allows causal testing of their roles in negative regulation of muscle contraction [1,6].
How CRISPR Can Be Used to Study GO:0045932 negative regulation of muscle contraction
Knockout
CRISPR knockout of genes such as DGK or SERCA can abolish their negative regulatory function, leading to enhanced contraction. This approach helps establish causality and identify drug targets [1,5].
Point Mutation
Introducing point mutations in thin filament genes (e.g., TNNI, TPM) that mimic patient mutations allows study of defective negative regulation and myopathy mechanisms.
Knock-in
Knock-in of reporter tags or disease-associated alleles (e.g., in CACNA1C) enables tracking of protein localization and function in live muscle cells.
Overexpression
Overexpression of negative regulators such as DGK or SERCA can suppress contraction, providing gain-of-function evidence and potential therapeutic strategies [1,5].
How EDITGENE Supports negative regulation of muscle contraction Research
Researchers studying negative regulation of muscle contraction-related genes often need to determine whether a candidate gene is causally involved in modulating contraction. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of muscle contraction research.
Frequently Asked Questions About negative regulation of muscle contraction
What is negative regulation of muscle contraction?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of muscle contraction, as defined by GO:0045932 [1,4].
What genes are involved in negative regulation of muscle contraction?
Key genes include DGK, p300, CBP, SERCA, TNNI, TNNT, TPM, and calcium channel genes such as CACNA1C [1,3,5,6,8].
How does calcium regulate muscle contraction negatively?
Calcium sequestration by SERCA into the sarcoplasmic reticulum lowers cytosolic calcium, promoting relaxation and negatively regulating contraction.
What is the role of DGK in muscle contraction?
DGK phosphorylates DAG to terminate Gq signaling, thereby reducing airway smooth muscle contraction.
How do thin filament mutations affect muscle contraction?
Mutations in thin filament proteins like troponin and tropomyosin impair the inhibitory regulation of contraction, leading to skeletal myopathies.
Can CRISPR be used to study negative regulation of muscle contraction?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in this process [1,3,6].
What diseases are associated with defective negative regulation of muscle contraction?
Asthma, gastric motility disorders, skeletal myopathies, and cardiovascular disorders such as hypertension [1,4,6,8].
How is negative regulation of muscle contraction measured experimentally?
Common methods include calcium imaging, contractility assays, and post-translational modification analysis [1,3,5].
What is the role of p300 and CBP in muscle contraction?
These acetyltransferases post-translationally modify contractile proteins, influencing contractile function and potentially contributing to negative regulation.
What is the clinical relevance of calcium-channel blockers?
Calcium-channel blocking agents reduce calcium entry, leading to negative regulation of muscle contraction and are used to treat hypertension and angina.
Conclusion
Negative regulation of muscle contraction (GO:0045932) is a vital biological process that prevents excessive contraction and maintains normal muscle function. Its molecular mechanisms involve calcium handling, Gq signaling feedback, thin filament regulation, and post-translational modifications. Dysregulation contributes to diseases such as asthma, gastric dysmotility, and skeletal myopathies. CRISPR-based models and advanced screening methods offer powerful tools to dissect these pathways and identify therapeutic targets. EDITGENE provides end-to-end services to support such research, from gene editing to bioinformatics.
References
- 1. Sharma P et al.. 2021. Diacylglycerol Kinase Inhibition Reduces Airway Contraction by Negative Feedback Regulation of Gq-Signaling.. Am J Respir Cell Mol Biol 65(6):658-671 PMID: 34293268
- 2. Mishima T et al.. 2025. Time-of-day effect of high-intensity muscle contraction on mTOR signaling and protein synthesis in mice.. Sci Rep 15(1):23702 PMID: 40610492
- 3. Meyer GA et al.. 2024. Insights into posttranslational regulation of skeletal muscle contractile function by the acetyltransferases, p300 and CBP.. J Appl Physiol (1985) 136(6):1559-1567 PMID: 38722753
- 4. Ozaki H et al.. 1992. Negative-feedback regulation of excitation-contraction coupling in gastric smooth muscle.. Am J Physiol 263(6 Pt 1):C1160-71 PMID: 1476162
- 5. Nakamura J et al.. 2023. Ca(2+) Dependent Formation/Collapse of Cylindrical Ca(2+)-ATPase Crystals in Scallop Sarcoplasmic Reticulum (SR) Vesicles: A Possible Dynamic Role of SR in Regulation of Muscle Contraction.. Int J Mol Sci 24(8) PMID: 37108240
- 6. Ochala J. 2008. Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction.. J Mol Med (Berl) 86(11):1197-204 PMID: 18574571
- 7. Korzeniewski B. 1998. Regulation of ATP supply during muscle contraction: theoretical studies.. Biochem J 330 ( Pt 3)(Pt 3):1189-95 PMID: 9494084
- 8. Leonard RG et al.. 1982. Calcium-channel blocking agents.. Clin Pharm 1(1):17-33 PMID: 6764159
